AzTrials
AzTrials

Postoperative PainPainseverityNCT06386250

Comparison of Regional Block, Caudal Block and Wound Infiltration in Inguinal Hernitomy

A study testing regional block, Caudal block and Epidural in people with Postoperative Pain, run by King Edward Medical University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Although Inguinal herniotomy in children is taken as a day care procedure, post-operative pain management still remain controversial in these cases and superiority of wound infiltration, caudal block or regional block over each isn't known. Read more about this study

Who is it for?
Ages 3 to 12 years
Conditions the study is for
Postoperative Pain
What is being tested?
regional block, Caudal block and Epidural
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 sitePakistan
Study dates
5 Jan 2019to 6 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Both Male and female inguinal hernia patients
  • Patients from 3-12 years age Exclusion Criteria
  • History of allergy to any drugs used in study documented on history .Infection at the site of regional, caudal or local infiltration, documented on clinical examination.
  • .Irreducible, obstructed or strangulated hernia, documented on clinical examination.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Muhammad Sharif

    Lahore, Punjab Province, 53711

Other trials in Pakistan

About this study

Official title: Comparison of Regional Block, Caudal Block and Wound Infiltration for Post-operative Pain Management in Children Undergoing Inguinal Herniotomy

Background: Although Inguinal herniotomy in children is taken as a day care procedure, post-operative pain management still remain controversial in these cases and superiority of wound infiltration, caudal block or regional block over each isn't known.

Objective: The objective of the study was compare regional block, caudal block and wound infiltration for post-operative pain management in children undergoing inguinal herniotomy

Read the detailed description

Three hundred patients rom the department of pediatric surgery, KEMU/Mayo Hospital, were randomized in three study groups by a computer generated table. Regional block group (Group A), wound infiltration group (Group B), caudal block group (Group C). . Patients were assessed for postoperative pain intensity using FLACC pain scale at 0, 1, 2, 4, 8, 24 hours after surgery in children less than 8 years of age. Wong-Baker Faces pain Scale at 0, 1, 2, 4, 8, 24 hours after surgery in children more than 8 years of age. Patients were discharged after 24 hours. If pain score ≥ 4 was given intravenously, Ketoralac. Urinary retention was observed after 24 hours, wound infection was observed after 7 days.

Being tested
regional block, Caudal block, Epidural
Keywords
Postoperative pain, inguinal herniotomy, children, regional block, caudal block, wound infilteration
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • regional blockProcedure or surgery

    Also called wound infilteration

    In group A, iliohypogastric and ilioinguinal nerves were blocked by using 0.25% bupivacaine 2ml/kg of combined with skin infiltration of adrenaline 1:200 000.

  • Caudal blockProcedure or surgery

    Also called infilteration with 0.25% bupivacaine

    In group B 0.25% bupivacaine 0.5ml/Kg was infiltrated at the surgical site.

  • EpiduralProcedure or surgery

    Also called injection Bupivacaine into epidural space

    In group C 0.25% Bupivacaine 1ml /kg was given into epidural space at L4-L5 or L5-S1.

Study groups in NCT06386250
Study groupRoleWhat they receive
Group AActive comparatorIn group A, iliohypogastric and ilioinguinal nerves were blocked by using 0.25% bupivacaine 2ml/kg of combined with skin infiltration of adrenaline 1:200 000.
Receives: Procedure: regional block; Procedure: Caudal block; Procedure: Epidural
Group BActive comparatorIn group B 0.25% bupivacaine 0.5ml/Kg was infiltrated at the surgical site.
Receives: Procedure: regional block; Procedure: Caudal block; Procedure: Epidural
Group CExperimentalIn group C 0.25% Bupivacaine 1ml /kg was given into epidural space at L4-L5 or L5-S1.
Receives: Procedure: regional block; Procedure: Caudal block; Procedure: Epidural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain intensity

    Patients were assessed for postoperative pain intensity using FLACC pain scale at 0, 1, 2, 4, 8, 24 hours after surgery in children less than 8 years of age. Wong-Baker Faces pain Scale at 0, 1, 2, 4, 8, 24 hours after surgery in children more than 8 years of age.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2024
  2. Study start5 Jan 2019
  3. Primary completion6 Jan 2020
  4. Study completion6 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Regional block group (Group A), wound infiltration group (Group B), caudal block group (Group C)
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06386250
Sponsor's protocol ID
0005
Acronym
Painseverity
Status last verified
Apr 2024
First submitted
13 Apr 2024
Last updated
26 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: will be shared on request

Questions about this trial

What is this clinical trial studying?

A study testing regional block, Caudal block and Epidural in people with Postoperative Pain, run by King Edward Medical University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain intensity (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in